Prostate News and Research

RSS

Relugolix and radiation therapy may be a safe, effective combination for treating prostate cancer

A high impact study led by Daniel Spratt, M.D., Vincent K. Smith Chair in Radiation Oncology at University Hospitals Seidman Cancer Center demonstrates the safety and efficacy of a novel oral hormone therapy, relugolix, in conjunction with radiation therapy for treating men with localized and advanced prostate cancer.

13 Mar 2024

Revolutionizing prostate cancer diagnostics with 3D pathology and deep learning

Prostate cancer stands as a prevalent threat to men's health, ranking second in cancer-related deaths in the United States.

11 Mar 2024

Why covid patients who could most benefit from paxlovid still aren’t getting it

Evangelical minister Eddie Hyatt believes in the healing power of prayer but "also the medical approach." So on a February evening a week before scheduled prostate surgery, he had his sore throat checked out at an emergency room near his home in Grapevine, Texas.

11 Mar 2024

Transformational $50 million gift from Kenneth C. Griffin to boost Sylvester's research footprint

The University of Miami today announced a transformational $50 million gift from Kenneth C. Griffin, Founder and Chief Executive Officer of Citadel and Founder of Griffin Catalyst, to Sylvester Comprehensive Cancer Center, part of the University of Miami Health System and the Miller School of Medicine.

6 Mar 2024

Common prostate cancer test may leave black men at increased risk of overdiagnosis

A new study from experts at the University of Exeter has found that a widely used test for prostate cancer may leave black men at increased risk of overdiagnosis.

29 Feb 2024

DiaCarta partners with OncoAssure for prostate cancer test commercialization

DiaCarta, Inc., a pioneer in molecular diagnostic test development for cancer and infectious diseases, based in California, today announced that it has established a strategic collaboration with OncoAssure Ltd, an Irish medical diagnostics company headquartered at NovaUCD in Dublin.

27 Feb 2024

Study demonstrates a feasible way to expand germline genetic testing for cancer patients

A new University of Kentucky Markey Cancer Center study published in JCO Precision Oncology demonstrates a feasible way to expand germline genetic testing for patients with cancer.

27 Feb 2024

Boston College biologist wins NIH grant to study viral insulins for cancer treatment

Boston College Assistant Professor of Biology Emrah Altindis has been awarded a five-year, $2.5-million grant from the National Institutes of Health to study viral insulins and mechanisms related to IGF-1 receptor protein inhibition and its potential applications in cancer treatment.

26 Feb 2024

Study reveals over 134,000 missed cancer diagnoses in the U.S. during COVID-19 pandemic

Over 134,000 cancer cases went undiagnosed in the U.S. during the first 10 months of the COVID-19 pandemic, according to a new University of Kentucky Markey Cancer Center study.

23 Feb 2024

How did COVID-19 impact cancer incidence trends in the US?

Cancer rate patterns from March to December 2020.

23 Feb 2024

CPRIT awards MD Anderson 16 grants to support cancer research and prevention

The University of Texas MD Anderson Cancer Center today was awarded 16 grants totaling over $25.5 million from the Cancer Prevention and Research Institute of Texas (CPRIT) in support of cancer screening, early detection and prevention programs, faculty recruitment, and groundbreaking cancer research across all areas of the institution.

21 Feb 2024

Finasteride may offer life-saving benefits beyond hair loss treatment

The drug finasteride, also known as Propecia or Proscar, treats male pattern baldness and enlarged prostate in millions of men worldwide.

20 Feb 2024

NIH-funded research enhances genetic testing for health equity

To prevent an emerging genomic technology from contributing to health disparities, a scientific team funded by the National Institutes of Health has devised new ways to improve a genetic testing method called a polygenic risk score.

20 Feb 2024

Selection, optimization, and validation of genetic tests for 10 common diseases

By analyzing millions of small genetic differences across a person's genome, researchers can calculate a polygenic risk score to estimate someone's lifetime odds of developing a certain disease.

19 Feb 2024

Associations between food additive emulsifiers and cancer risk

Researchers assessed associations between food emulsifier intake and cancer risk among NutriNet-Santé study participants.

19 Feb 2024

What factors are associated with recent prostate-specific antigen screening in transgender women?

A new study reports on factors associated with prostate cancer screening among transgender women.

19 Feb 2024

Study demonstrates chemo-preventive properties of alpha-santalol against prostate cancer development

Extracted from the core of sandalwood trees (santalum album tree), sandalwood oil has been used for many centuries by several cultures throughout the world for perfume, soaps, incense and candles.

13 Feb 2024

Plant-based diet linked to less erectile dysfunction, urinary incontinence in prostate cancer patients

A diet that limits meat and dairy but is rich in fruits, vegetables, grains, and nuts is linked to less erectile dysfunction, urinary incontinence, and other common side effects seen in prostate cancer patients, a new study shows.

13 Feb 2024

Smoking, drinking, and dietary habits linked to head and neck cancer risk, study finds

Study in JAMA Otolaryngology-Head & Neck Surgery examines the link between smoking, drinking, and dietary habits and the risk of developing head and neck cancer (HNC), highlighting the significant impact of lifestyle choices on cancer risk.

12 Feb 2024

Representation matters to Black patients seeking prostate cancer information online, study shows

For Black men with prostate cancer, racial representation is a key factor affecting trust in websites offering information on prostate cancer, reports a study in the March issue of The Journal of Urology, an Official Journal of the American Urological Association (AUA).

9 Feb 2024

Prostate News and Research

Relugolix and radiation therapy may be a safe, effective combination for treating prostate cancer

Revolutionizing prostate cancer diagnostics with 3D pathology and deep learning

Why covid patients who could most benefit from paxlovid still aren’t getting it

Transformational $50 million gift from Kenneth C. Griffin to boost Sylvester's research footprint

Common prostate cancer test may leave black men at increased risk of overdiagnosis

DiaCarta partners with OncoAssure for prostate cancer test commercialization

Study demonstrates a feasible way to expand germline genetic testing for cancer patients

Boston College biologist wins NIH grant to study viral insulins for cancer treatment

Study reveals over 134,000 missed cancer diagnoses in the U.S. during COVID-19 pandemic

How did COVID-19 impact cancer incidence trends in the US?

CPRIT awards MD Anderson 16 grants to support cancer research and prevention

Finasteride may offer life-saving benefits beyond hair loss treatment

NIH-funded research enhances genetic testing for health equity

Selection, optimization, and validation of genetic tests for 10 common diseases

Associations between food additive emulsifiers and cancer risk

What factors are associated with recent prostate-specific antigen screening in transgender women?

Study demonstrates chemo-preventive properties of alpha-santalol against prostate cancer development

Plant-based diet linked to less erectile dysfunction, urinary incontinence in prostate cancer patients

Smoking, drinking, and dietary habits linked to head and neck cancer risk, study finds

Representation matters to Black patients seeking prostate cancer information online, study shows

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News